Although immunization with tetanus toxoid cannot be expected to produce an adequate permanent immunity, a number of investigators have confirmed and extended the observation of Ramon3 to the effect that an organism, once immunized, will respond to further injections of toxoid with an accelerated and increased antitoxin production. That this response to the "injection de rappel" does occur has been adequately and clearly demonstrated, but it has not been entirely proved that this recall response takes place rapidly enough to provide effective protection against infection with tetanus. It was the purpose of this investigation to add to the available information on this point.
The subjects of this investigation were 42 students of Yale University, all in general good health, who had been immunized against tetanus, either because they had a definite history of serum sickness or were known to be allergic to other substances, and hence, presumably, to horse serum. The age range was from 18 to 21 years. These subjects had received two 1 cc. doses of commercial tetanus toxoid, alum precipitated (APT). The interval between the two doses averaged 63 + 8 days. The recall injection was given after 283 i 28 days. The variation in this interval is due to the fact that primary immunization was done routinely rather than experimentally, and hence occurred through the year. The procedure in these tests was essentially as follows:
After a 10 cc. specimen of blood was removed for titration of residual antitoxin, the subject was given a recall dose of 1 cc. APT intramuscularly. Blood samples for antitoxin titration were again taken on the 5th and 10th days after the recall injection. A 5-day interval was selected because Cowles' has shown that most subjects then have their first significant rise in antitoxin.
The 10-day interval was selected as being the approximate time of maximum 76  67  63  69  88  61  65  56  60  60  80  55  67  54  62  74  52  69  79  70  59  75  65  61  67  71  61  60  59  76 
Results
Most of the subjects injected developed a local reaction, but only one subject (case 14) experienced a general reaction. This appeared some 8 hours after injection and consisted of general malaise and some arthralgia, with a temperature of 101°F. In no case was there urticaria or generalized lymphadenopathy. Of the 42 subjects studied, 4 were omitted from the average of residual levels. Case 35 had received a single dose and had failed to complete his immunization until 406 days later, when he was given two 1 cc. injections 61 days apart. Another, case 15, because of an injury was given a recall dose 177 days after his primary immunization. The levels of these two cases were higher than the general average, although within the range, being 0.2 and 0.4 units per cc. respectively. Two other cases, Nos. 30 and 40, were omitted because they had residual levels far above the average range, i.e., 1.5 and 5.0 units respectively.
The average residual level in the sera of the remaining 38 subjects (283 days after the last dose of toxoid) was 0.11 4 0.07 unit per cc. Of all cases, 52 per cent had serum levels of 0.1 unit or more. Only one had less than 0.01 unit.
Response to the recall dose The.average serum antitoxin level of the 38 cases (omitting the 4 previously mentioned) on the 5th day after the recall dose of toxoid was 0.53 i 0.26 unit per cc. Three cases had less than 0.1 unit per cc. Case 41, who had had a residual level of 0.06 unit per cc., had only 0.04 unit per cc. on the 5th day after recall, but on the 10th day he had a level of 6 units per cc. Case 36, with a residual level of 0.02 unit, had only 0.015 unit 5 days after recall, but 3 units per cc. on the 10th day. The third of these poor reactors had 0.08 unit per cc. before recall and only 0.06 unit per cc. 5 days after. No blood sample could be obtained from this subject on the 10th day. Of all cases titrated on the 5th day, 92 per cent had 0.1 unit or more per cc. and 49 per cent had 0.5 or more unit per cc.
The average serum antitoxin level on the 10th day (excluding case 40, which showed 25 units per cc.) was 4.3 i 2.1 units per cc. All cases had more than 0.5 unit per cc.; 92 per cent, i.e., all but 2 of 37 cases, had 1 unit or more per cc., and 49 per cent had 4 units or more per cc.
Seven of the cases mentioned were tested 330 days after the recall dose, and the serum levels of these were 0.01 5, 0.06, 0.4, 0.5, 0.7, 1.5, and 1.5 units per cc.
Discussion
One must conclude from a review of the experimental work, particularly that of Cowles' and of Sneath,4 that at least 0.1 unit per cc. of antitoxin must be present in the serum of a subject before he can be considered adequately protected against tetanus. One must also consider the adequacy of the serum level in terms of time as well as of quantity. While the series presented in this. paper shows that the average level of antitoxin following primary immunization was above 0.1 unit per cc., an initial immunization with toxoid certainly could not be counted on to provide protection, since 48 per cent of the subjects had less than this arbitrary minimal level 9 months after initial immunization. Following the recall dose, on the 5th day, 8 per cent of this series had less than the minimum of 0.1 unit per cc. All, however, had more than 0.01 unit per cc., and it can probably be assumed that the incubation of an infection with tetanus would be sufficiently prolonged in this small group of slow reactors for the further increase in antitoxin to take place. That such a further increase of antitoxin can occur is shown by the fact that on the 10th day following the recall dose, all cases had more than 0.5 unit per cc., a level probably adequate for all but overwhelming infections.
Direct proof of the adequacy of active immunization against tetanus is still lacking, but should be forthcoming in the next few years. Ramon3 has reported the immunization of a million persons against tetanus, with no case of the disease as yet reported.
The many disadvantages inherent in the use of prophylactic antitoxin, such as its transitory effectiveness and the discomforts and dangers attendant upon the introduction of its usual vehicle, horse serum, should encourage further study of the problems of active immunization. Conclusions 1. Of 42 individuals examined 9 months after primary immunization with alum-precipitated tetanus toxoid, 52 per cent had serum antitoxin levels of more than 0.1 unit per cc.,-an average level of 0.11 i 0.07 unit per cc.
2. Five days after a recall dose of toxoid the antitoxin levels in these subjects had risen to an average of 0.53 4t 0.26 unit per cc., 92 per cent having 0.1 or more unit per cc.
3. Ten days after the recall dose the average level was 4.5 i 2.1 units per cc., every subject having more than 0.5 unit per cc.
4. Ten months after the recall dose 7 cases had an average of 0.67 ± 0.48 unit per cc., 5 of them having more than 0.1 unit per cc.
